Patents and the Federal Circuit, Fourteenth Edition
Patents and the Federal Circuit is the most complete commentary available on the state of patent law. This monumental reference places federal patent law decisions, both high-profile and less-celebrated, into an analytical framework that demonstrates their relevance and impact.
This landmark reference deals with both the high-profile cases and the “uncelebrated decisions” that tend to slip under the radar and fits them into an analytical framework that reveals their true significance. Patents and the Federal Circuit addresses ever-changing issues and developments in substantive patent law, infringement litigation, and procedure. The authors distill the opinions issued by the primary source of governing law on patents, providing convenient, one-source access to controlling case law.
The Fourteenth Edition includes a new appendix with guidance on the time to decision for the Federal Circuit’s patent decisions, including statistics on the time from argument to issuance of a precedential decision by judge.
Discussion of new Supreme Court and key Federal Circuit decisions include:
- Supreme Court decisions through June 2019, including Helsinn Healthcare SA v. Teva Pharmaceuticals USA Inc., 139 S. Ct. 628 (2019), and Return Mail, Inc. v. U.S. Postal Serv., 139 S. Ct. 1853, 1867 (2019).
- Decisions concerning the Federal Circuit’s evolving precedent on patent eligibility under 35 U.S.C. 101, including, inter alia, Roche Molecular Sys., Inc. v. Cepheid, 905 F.3d 1363, 1372 (Fed. Cir. 2018); SAP Am., Inc. v. InvestPic, LLC, 898 F.3d 1161, 1162 (Fed. Cir. 2018); Voter Verified, Inc. v. Election Sys. & Software, LLC, 887 F.3d 1376 (Fed. Cir. 2018); Aatrix Software, Inc. v. Green Shades Software, Inc., 882 F.3d 1121, 1125 (Fed. Cir. 2018); Berkheimer v. HP, Inc., 881 F.3d 1360 (Fed. Cir. 2018); Praxair Distrib. v. Mallinckrodt Hosp. Prods. IP, 890 F.3d 1024, 1032 (Fed. Cir. 2018); In re Marco Guldenaar Holding B.V., 911 F.3d 1157 (Fed. Cir. 2018); In re Nordt Dev. Co., LLC, 881 F.3d 1371, 1374-75 (Fed. Cir. 2018); and Vanda Pharms. Inc. v. West-Ward Pharms. Int’l Ltd., 887 F.3d 1117, 1121 (Fed. Cir. 2018).
- Revisions to address U.S. Patent Trial and Appeal Board procedure for post-grant proceedings under the America Invents Act in light of the rapidly-evolving law in this area
Robert L. Harmon (deceased) was a partner with the Chicago intellectual property law firm of Brinks Gilson & Lione (Brinks) for 33 years, where he specialized in patent litigation.
Laura A. Lydigsen is a partner at Brinks, where she focuses her practice on Hatch-Waxman litigation and appellate practice. She currently serves as chair of the firm’s Appellate Practice Group through which she enjoys working on Federal Circuit appeals across a broad range of technologies.